Trillium Therapeutics (TRIL.V) announced today that the Company has entered into a definitive agreement under which Pfizer Inc. will acquire Trillium. “We’re delighted to announce Pfizer’s proposed…
Robertson
Consortium Inc. (TIUM.U) today announced the opening of Fluent Mechanicsburg, the Company’s 2nd retail location in Pennsylvania and its 28th dispensary overall. “We are thrilled to open our second…
Greenpro Capital Corp. (GRNQ.Q) announced today that its incubator company, Angkasa-X, has signed a Memorandum of Understanding (MOU) with Silkwave Holdings Ltd. in forming a joint-venture strategic partnership to…
The Blooming Plant-Based Market When plant-based foods first began circulating in Ontario, I was skeptical. Don’t get me wrong, I have nothing against plant-based diets. Keep in mind, when I…
Plurilock Security (PLUR.V) announced today that it has received a USD$794,000 purchase order from a California state healthcare agency under the NASPO ValuePoint program. As cyber threats continue to…
PharmaCyte Biotech (PMCB.Q) released a statement from Kenneth L. Waggoner, the Chief Executive Officer of PharmaCyte, on August 16, 2021. In this statement, Mr. Waggoner comments on the Company’s…
AzurRx BioPharma (AZRX.Q) today announced positive topline results from its Phase 2 Combination Trial evaluating MS1819 in combination with the current standard of care, porcine-derived pancreatic enzyme replacement therapy…
Medexus Pharmaceuticals (MDP.T) today announced its financial results and provided a business update for the three-month period ended June 30, 2021. “We continued to see pressure on IXINITY® ex-factory…
Aequus Pharmaceuticals (AQS.V) and reVision Therapeutics today announced a collaboration on the development of a therapy for Stargardt disease. The agreement will provide the Company with the option to…
Manganese X (MN.V) announced today that the TSX Venture Exchange has issued its conditional listing approval for the previously announced spinout transaction of certain assets into Graphano Energy Ltd….